Excluded medicinal items and medicines for brand consideration

The List of Excluded Medicinal Items (LEMI) and the List of Medicines for Brand Consideration (LMBC) help support prescribers to prescribe medicines by the active ingredient by providing best practice guidance for specification of brand.

About the LEMI

The List of Excluded Medicinal Items (LEMI) is a record of medicines are legally excluded from active ingredient prescribing (AIP) requirements. The legislation that supports the AIP initiative only applies to PBS and RPBS prescriptions, so the LEMI only contains medicines listed on the PBS or RPBS. We cannot consider non-PBS items for inclusion in the LEMI. 

Inclusion of medicines on the LEMI is based on a set of principles which are included in the user guide.

Prescribers should only prescribe items on the LEMI by the brand name for practical and/or safety purposes. Medical software programs will generally default to brand name only for items on the LEMI.

We review the LEMI 3 times a year. Anyone can make a request for us to consider a medicine for inclusion in, or removal from, the LEMI at any time by emailing us with appropriate evidence. We publish dates of upcoming LEMI reviews; requests for consideration close 2 weeks prior to the published review date.

If you have made a request for consideration, we may ask for more information. You can also resubmit a request at any time, even if we have previously considered the medicine. 

We publish the LEMI consideration outcomes in the Outcomes Table.

About the LMBC

Under the AIP initiative, prescribers can include the medicine’s brand name after the active ingredient name if they consider it appropriate. The List of Medicines for Brand Consideration (LMBC) is a resource for health professionals to support safe prescribing and dispensing of medicines which may be of higher risk.

The LMBC includes a list of recommended medicines for further consideration by prescribers prior to deciding whether to prescribe by brand and active ingredient, or by active ingredient alone.  

The LMBC is not mandated and is not a legal document, so there is no requirement for prescribers to include a brand name for prescription medicines included in the LMBC. Some software systems will still default to AIP for non-PBS items.  

Non-PBS medicines are also able to be considered for inclusion in the LMBC if they meet the required principles for inclusion.

The principles for inclusion of medicines on the LMBC are detailed in the user guide.

We review the LMBC 3 times per year. Anyone can submit a request (with appropriate evidence) to us to consider a medicine for inclusion in, or removal from, the LMBC at any time. We also accept requests to vary the details of existing medicines listed in the LEMI or LMBC. 

If you have made a request for consideration, we may ask for more information. You can also resubmit a request at any time, even if we have previously considered the medicine. 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.